Joshua Hsu1, Aravind Krishnan1, Sul A Lee2, Jefferey M Dodd-O3, Bo S Kim4, Peter Illei5, Kristine Yarnoff3, Abdel A Hamad5, Hamid Rabb2, Errol L Bush6. 1. Division of Thoracic Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Md. 2. Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Md. 3. Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Md. 4. Divisions of Pulmonary and Critical Care, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md. 5. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Md. 6. Division of Thoracic Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: errol.bush@jhu.edu.
Abstract
OBJECTIVE: Lung ischemia-reperfusion injury (IRI) is a common complication after lung transplantation, and immune cells have been implicated in modulating outcomes. We hypothesized that a newly described subset of αβ T-cell receptor positive cells; that is, CD4-CD8- (double negative [DN]) T cells, are found in lungs and can protect against lung IRI. METHODS: Ischemia was induced in C57BL/6 mice by left pulmonary artery and vein occlusion for 30 minutes followed by 180 minutes of reperfusion. These mice were paired with sham hilar dissected surgical controls. In mice undergoing IRI, adoptive transfer of DN T cells or conventional T cells was performed 12 hours before occlusion. Flow cytometry was used to quantify T cells and inflammatory cytokines, and apoptotic signaling pathways were evaluated with immunoblotting. Lung injury was assessed with Evans blue dye extravasation. RESULTS: DN T cells were significantly higher (5.29% ± 1% vs 2.21% ± 3%; P < .01) in IRI lungs and secreted higher levels of interleukin-10 (30% ± 5% vs 6% ± 1%; P < .01) compared with surgical sham controls. Immunoblotting, hematoxylin and eosin staining and Evans blue dye demonstrated that adoptive transfer of DN T cells significantly decreased interstitial edema (P < .01) and attenuated apoptosis/cleaved caspase-3 expression in the lungs following lung IRI (P < .01). CONCLUSIONS: DN T cells traffic into lungs during IRI, and have tissue protective functions regulating inflammation and apoptosis. We propose a potential novel immunoregulatory function of DN T cells during lung IRI.
OBJECTIVE:Lung ischemia-reperfusion injury (IRI) is a common complication after lung transplantation, and immune cells have been implicated in modulating outcomes. We hypothesized that a newly described subset of αβ T-cell receptor positive cells; that is, CD4-CD8- (double negative [DN]) T cells, are found in lungs and can protect against lung IRI. METHODS:Ischemia was induced in C57BL/6 mice by left pulmonary artery and vein occlusion for 30 minutes followed by 180 minutes of reperfusion. These mice were paired with sham hilar dissected surgical controls. In mice undergoing IRI, adoptive transfer of DN T cells or conventional T cells was performed 12 hours before occlusion. Flow cytometry was used to quantify T cells and inflammatory cytokines, and apoptotic signaling pathways were evaluated with immunoblotting. Lung injury was assessed with Evans blue dye extravasation. RESULTS: DN T cells were significantly higher (5.29% ± 1% vs 2.21% ± 3%; P < .01) in IRI lungs and secreted higher levels of interleukin-10 (30% ± 5% vs 6% ± 1%; P < .01) compared with surgical sham controls. Immunoblotting, hematoxylin and eosin staining and Evans blue dye demonstrated that adoptive transfer of DN T cells significantly decreased interstitial edema (P < .01) and attenuated apoptosis/cleaved caspase-3 expression in the lungs following lung IRI (P < .01). CONCLUSIONS: DN T cells traffic into lungs during IRI, and have tissue protective functions regulating inflammation and apoptosis. We propose a potential novel immunoregulatory function of DN T cells during lung IRI.
Authors: S M Fiser; C G Tribble; S M Long; A K Kaza; J T Cope; V E Laubach; J A Kern; I L Kron Journal: J Thorac Cardiovasc Surg Date: 2001-06 Impact factor: 5.209
Authors: Elbert P Trulock; Leah B Edwards; David O Taylor; Mark M Boucek; Berkeley M Keck; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2006-08 Impact factor: 10.247
Authors: Ashish K Sharma; Damien J LaPar; Matthew L Stone; Yunge Zhao; Christopher K Mehta; Irving L Kron; Victor E Laubach Journal: Am J Respir Crit Care Med Date: 2016-05-01 Impact factor: 21.405
Authors: B Krishnadasan; B Naidu; M Rosengart; A L Farr; A Barnes; E D Verrier; M S Mulligan Journal: J Thorac Cardiovasc Surg Date: 2002-04 Impact factor: 5.209
Authors: M J Burne; F Daniels; A El Ghandour; S Mauiyyedi; R B Colvin; M P O'Donnell; H Rabb Journal: J Clin Invest Date: 2001-11 Impact factor: 14.808
Authors: Maria Teresa Gandolfo; Hye Ryoun Jang; Serena M Bagnasco; Gang-Jee Ko; Patricia Agreda; Shailesh R Satpute; Michael T Crow; Landon S King; Hamid Rabb Journal: Kidney Int Date: 2009-07-22 Impact factor: 10.612
Authors: Leo M Gazoni; Victor E Laubach; Daniel P Mulloy; A Bellizzi; Eric B Unger; Joel Linden; Peter I Ellman; Turner C Lisle; Irving L Kron Journal: J Thorac Cardiovasc Surg Date: 2007-11-26 Impact factor: 5.209
Authors: Ana P M Serezani; Bruno D Pascoalino; Julia M R Bazzano; Katherine N Vowell; Harikrishna Tanjore; Chase J Taylor; Carla L Calvi; A Scott McCall; Matthew D Bacchetta; Ciara M Shaver; Lorraine B Ware; Margaret L Salisbury; Nicholas E Banovich; Peggy L Kendall; Jonathan A Kropski; Timothy S Blackwell Journal: Am J Respir Cell Mol Biol Date: 2022-07 Impact factor: 7.748
Authors: Parth M Patel; Margaret R Connolly; Taylor M Coe; Anthony Calhoun; Franziska Pollok; James F Markmann; Lars Burdorf; Agnes Azimzadeh; Joren C Madsen; Richard N Pierson Journal: Front Immunol Date: 2021-09-09 Impact factor: 7.561